The present invention discloses novel macrocyclic compounds which have HCV
protease inhibitory activity as well as methods for preparing such
compounds. In another embodiment, the invention discloses pharmaceutical
compositions comprising such macrocycles as well as methods of using them
to treat disorders associated with the HCV protease.
A invenção atual divulga os compostos macrocyclic da novela que têm a atividade inhibitory do protease de HCV as.well.as métodos para preparar tais compostos. Em uma outra incorporação, a invenção divulga as composições pharmaceutical que compreendem tais macrocycles as.well.as métodos de usá-los tratar os disorders associados com o protease de HCV.
